排序方式:
1.Novel nano-drug delivery system for natural products and their application
Huang, Li, Huang, Xu
More...
Huang, Li, Huang, Xue Hua, Yang, Xi, Hu, Jia Qin, Zhu, Yi Zhun, Yan, Pei Yu, Xie, Ying
Less
Pharmacological Research[1043-6618],
Published 2024,
Volume 201,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 16
2023影響因子:
9.1
2.Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Xie, Y, Feng, SL, He
More...
Xie, Y, Feng, SL, He, F, Yan, PY, Yao, XJ, Fan, XX, Leung, ELH, Zhou, H
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2022,
Volume 186,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 11
2023影響因子:
9.1
发表年影響因子:
9.3
3.Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells
Jiang, ZeBo, Xu, Con
More...
Jiang, ZeBo, Xu, Cong, Wang, Wenjun, Zhang, YiZhong, Huang, JuMin, Xie, YaJia, Wang, QianQian, Fan, XingXing, Yao, XiaoJun, Xie, Chun, Wang, XuanRun, Yan, PeiYu, Ma, YuPo, Wu, QiBiao, Leung, Elaine LaiHan
Less
Pharmacological Research[1043-6618],
Published 2021,
Volume 169,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 17
2023影響因子:
9.1
发表年影響因子:
10.334
4.Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling
Li, JX, Li, RZ, Sun,
More...
Li, JX, Li, RZ, Sun, A, Zhou, H, Neher, E, Yang, JS, Huang, JM, Zhang, YZ, Jiang, ZB, Liang, TL, Ma, LR, Wang, J, Wang, XR, Fan, XQ, Huang, J, Xie, Y, Liu, L, Tang, L, Leung, ELH, Yan, PY
Less
PHARMACOLOGICAL RESEARCH[1043-6618],
Published 2021,
Volume 171,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 37
2023影響因子:
9.1
发表年影響因子:
10.334